Efroze Chemical Industries analyzes all the parameters pertaining to expansion opportunities and the structure of the destination pharmaceutical market. On the basis of documentary and factual data studied in co-operation with the perceived partners, Efroze Chemical Industries assesses the conditions for setting up licensing arrangements of international brands from Research-based Corporations.

· Boryung, Korea
· Italfarmaco, Italy
· Shin Poong, Korea
· Joint-Venture with Otsuka, Japan
· Maple Pharmaceuticals, Canada

Efroze is promoting more than 50 branded products of different therapeutic classes to 9000 Doctors, inline with top companies, through its field force of over 150 personnel. Backed by a dedicated distribution channel of Distributors for Trade and Institutional Sales.

A highly specialized information technology department, a corporate website and a range of software in various languages - English, Russian, French and Arabic - for customized promotion development, exist in Efroze to support our market development operations. A fair support is also obtained by a good know-how of handling Government departments in Pakistan, specially regulatory affairs.

Efroze, a highly credible name in the industry, is committed with the aim of serving the suffering humanity. Today it stands as one of the  leading  national pharmaceutical  organizations  in the  country with a nationwide reputation of  marketing quality products for the ailing humanity.

Efroze is a progressive company with a dynamic management and dedicated staff geared towards achieving the ultimate level of professionalism. Highly qualified personnel with extensive practical and theoretical knowledge of the pharmaceuticals field combine their expertise to make Efroze an exemplary commercial as well as service organization.